The carbon footprint of surgical and nonsurgical skin cancer appointments
Clinical and Experimental Dermatology · 2026
DOI: 10.1093/ced/llag229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Jake T W Williams und 5 weiteren Autor:innen. Beteiligte Einrichtung: The University of Sydney School of Public Health, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Carbon Footprint, Skin Neoplasms, Melanoma, Appointments and Schedules. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine and Health, NHMRC Investigator, NHMRC Centre for Research Excellence.
Abstract (Originalsprache)
Background
The carbon emissions of the healthcare sector are large and there is a growing body of literature dedicated to estimating the carbon footprint of healthcare activities. The carbon footprint of dermatology services is of particular interest in Australia due to the high burden of melanoma and nonmelanoma skin cancer and the geographically dispersed population.
Objectives
To estimate the carbon emissions of appointments for dermoscopy-guided full-skin examination, total-body photography and the excision of a lesion suspicious for melanoma or other skin cancers for patients attending specialist dermatology clinics in Sydney, Australia.
Methods
The carbon footprint of each appointment type was estimated in kilograms CO2 equivalent (kg CO2-e) using process-based life cycle assessment. We included patient transport, single-use equipment, reusable equipment requiring treatment, and energy. Each appointment type was investigated as a mutually exclusive event.
Results
Total carbon emissions were 11.1 kg CO2-e [95% confidence interval (CI) 1.93–55.5] for full-skin examination, 10.8 kg CO2-e (95% CI 1.60–54.5) for total-body photography and 12.2 kg CO2-e (95% CI 2.92–61.6) for the excision of a lesion suspicious for melanoma. Patient transport was responsible for 10.7 kg CO2-e for each appointment type.
Conclusions
Carbon emissions associated with dermoscopy-guided full-skin examination, total-body photography and the excision of a lesion suspicious for melanoma or other skin cancers were similar and largely driven by patient transport. Efforts to reduce emissions related to skin cancer care should focus on reducing the need for patients to attend the clinic, where it is clinically safe to do so.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The University of Sydney School of Public Health, Camperdown, NSW, Australia.
- Heat and Health Research Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
- NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
- Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
- Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
ORCID-Profile: Jake T W Williams, Katy J L Bell, Rachael L Morton, Linda K Martin
Förderung
- Faculty of Medicine and Health
- NHMRC Investigator
- NHMRC Centre for Research Excellence
- Australian Government
Zitieren
APA
Williams, J. T. W., Bell, K. J. L., Morton, R. L., Guitera, P., Martin, L. K., & McAlister, S. (2026). The carbon footprint of surgical and nonsurgical skin cancer appointments. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag229
Vancouver
Williams JTW, Bell KJL, Morton RL, Guitera P, Martin LK, McAlister S. The carbon footprint of surgical and nonsurgical skin cancer appointments. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag229
BibTeX
@article{Williams2026,
author = {Williams, Jake T W and Bell, Katy J L and Morton, Rachael L and Guitera, Pascale and Martin, Linda K and McAlister, Scott},
title = {The carbon footprint of surgical and nonsurgical skin cancer appointments},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag229}
}
EUVIMED